Is the reverse vaccinology idea becoming exhausted?

Area of Science:

• Vaccinology
• Computational Biology
• Bioinformatics

Background:

• Reverse vaccinology (RV) utilizes genomic data for antigen discovery, aiming to revolutionize vaccine design.
• Recent trends show plateauing RV publications, declining impact factors, and a shift towards technical fields, indicating waning interest.
• The real-world impact of RV on vaccine development for pandemics, antimicrobial resistance, and routine immunization remains limited.

Purpose of the Study:

• To analyze the current state and impact of reverse vaccinology in vaccine development.
• To identify factors contributing to the plateauing interest and limited real-world application of RV.
• To propose strategies for revitalizing RV and enhancing its contribution to vaccinology.

Main Methods:

• Bibliometric analysis of RV publications to track trends and journal impact factors.
• Qualitative assessment of RV study characteristics, including theoretical focus, experimental validation, and target pathogen relevance.
• Review of vaccine development pipelines and stakeholder reliance on traditional vaccine components.

Main Results:

• RV publications have plateaued after a surge, with declining impact factors and a shift in disciplinary focus.
• A significant portion of RV studies are theoretical, lack experimental validation, and focus on redundant or marginally relevant targets.
• Limited integration of RV with complementary frameworks (systems vaccinology, AI) and a disconnect with policymakers hinder translational efforts.

Conclusions:

• RV's potential is undermined by a lack of multidisciplinary collaboration, experimental validation, and strategic alignment.
• Integrating RV with systems vaccinology, AI, and translational efforts is essential to bridge computational insights with late-stage vaccine development.
• Stakeholder engagement and a focus on high-priority pathogens are critical for RV to regain relevance and impact vaccine portfolios.